Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print

Latest Articles in Healthcare

In The Spotlight For New Reasons

Several Indian pharma companies and CROs were issued warning letters last year for fudging data

Read More

‘We’ve To Be Ready For Scrutiny’

G.N. Singh tells Himani Chandna he is ready to take on even more. He has, in fact, asked the industry how his agency can reduce the regulatory burden to make it easier to do business in India

Read More

Finding New Markets To Grow

India’s pharma exports are shrinking. Focusing on smaller, emerging markets can reverse the trend

Read More

Is It The End Of Pharma’s Dream Run?

Unless the Indian pharma industry — not long ago touted as the pharmacy of the world — strives to be more than just a plain generics player

Read More

Basic Knowledge Of These Subjects Will Be Most Demanding For Jobs In Future

Gates told LinkedIn executive editor Daniel Roth, “People proficient in these subjects will be the agents of change for all the institutions.”

Read More

Indian-American Develops Handheld Device For Cervical Cancer

The device, developed with funding from the National Institutes of Health, has a colposcope design that resembles a pocket-sized tampon with lights and a camera at one end.

Read More

Suven Life Sciences Secures Product Patents In Israel, Macau, South Korea

The product patents are corresponding to the New Chemical Entities (NCEs) for the treatment of disorders associated with Neurodegenerative diseases and these Patents are valid through 2032.

Read More

Lupin Sets Off Down Indian Pharma's Long Road To Redemption

More than 40 plants have been banned by the FDA for issues ranging from data fraud to hygiene since India's then-largest drugmaker Ranbaxy was pulled up for serious violations in 2008

Read More

Zydus starts second trial of medicine treating anemia

Zydus today (5 July,2017) has announced the initiation of a phase II trial investigating ZYAN1, an oral hypoxia- inducible factor prolyl hydroxylase inhibitor (HIF-PHI), as a treatment for anemia associated with chronic kidney disease (CKD).

Read More

'Indian Pharma Sector Growth Likely To Come Down To Single Digit'

In ICRA’s view, continued regulatory interventions in domestic market will put some pressure in near term though long term growth prospects remain healthy given increasing penetration, accessibility and continued new launches by players.

Read More

No Price Change In 78% Of Actively Used Drugs Post GST: NPPA

The National Pharmaceutical Pricing Authority (NPPA) has already announced provisional ceiling prices of 761 medicines, including anti-cancer, HIV, diabetes and antibiotics, with a majority being reduced ahead of the GST implementation.

Read More

Wellness: Back To The Roots

Armed with investment in R&D and innovation, India Inc. is now betting big on healing with herbs

Read More

Where Clarity Is A Prime Concern

Some unorganised players in the industry could suffer

Read More

'Women In Rural India Register Gains In Nutrition, Food Security'

Anemia is a leading cause of maternal deaths in India. In India, half of children under three are either stunted or underweight due to malnutrition, and 79 percent are anemic.

Read More

Lupin Founder DB Gupta Passes Away

Indian drug industry losses another doyen after Dr. Parvinder Singh, IA Modi and Ramanbhai Patel

Read More